You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Discovery's clients will be able to receive genomic sequencing services, including exome sequencing and analysis for $250 through its Vitality program.
The deal provides Tufts Health Plan members with access to the ConfirmMDx test for prostate cancer.
The agreement covers 43 million people in the US and includes Sequenom's MaterniT21 Plus and HerediT CF and Universal tests.
The agreements with the PPOs bring the total number of Americans with covered access to Biocept's tests to about 31 million.
Starting Sept. 15, Cologuard will be available to BCBS' 500,000 members through their physicians without a co-payment or co-insurance.
The contracts with Stratose, Three Rivers Provider Network, and Fortified Provider Network provide coverage for Opko's testing services.
The medical policy update makes the unnamed insurer the first commercial plan to cover ThyraMIR, a microRNA gene expression classifier launched earlier this year.
The change makes Anthem one of the first major payors to say that NIPT is medically necessary for the non-high-risk pregnancy population.
Through the arrangement, Paradigm's test, which sequences both DNA and RNA, will be available to the more than 15 million US members in Three River's network.
The tool is aimed at facilitating a simple and efficient process that payors can use to asses a CDx's value and if further technology assessments are warranted.
The World Bank is seeking approval for a $12 billion plan to provide low-income nations with funds to procure SARS-CoV-2 vaccines, according to Reuters.
The Washington Post reports that Herbert Tabor, who worked at the US National Institutes of Health for 77 years, has died at 101.
Science writes that public health officials and others are debating whether cycle threshold values should be included on SARS-CoV-2 results.
In Nucleic Acids Research this week: online database of SARS-CoV-2 protein structures, atlas of the human brain, and more.